Cargando…

Increased expression of METTL3 in pancreatic cancer tissues associates with poor survival of the patients

BACKGROUND: Methyltransferase-like 3 (METTL3) expression could be found in various normal and cancerous tissues. As of now, the clinical significance of METTL3 expression in human pancreatic cancer (PC) tissues still remains to be understood. Our present study aims to investigate the prognostic valu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yuan, Huang, Hao, Zhu, Yulan, Xu, Bin, Chen, Junjun, Liu, Yingting, Zheng, Xiao, Chen, Lujun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442951/ https://www.ncbi.nlm.nih.gov/pubmed/36058919 http://dx.doi.org/10.1186/s12957-022-02743-7

Ejemplares similares

The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma
por: Zhu, Dawei, et al.
Publicado: (2022)

IL1R2 increases regulatory T cell population in the tumor microenvironment by enhancing MHC-II expression on cancer-associated fibroblasts
por: Chen, Lujun, et al.
Publicado: (2022)

Prognostic values of tissue-resident CD8(+)T cells in human hepatocellular carcinoma and intrahepatic cholangiocarcinoma
por: Chen, Lujun, et al.
Publicado: (2023)

TIGIT Blockade Exerts Synergistic Effects on Microwave Ablation Against Cancer
por: Chen, Yaping, et al.
Publicado: (2022)

Decreased IFIT2 Expression In Human Non-Small-Cell Lung Cancer Tissues Is Associated With Cancer Progression And Poor Survival Of The Patients
por: Su, Wenya, et al.
Publicado: (2019)

LAG3 blockade coordinates with microwave ablation to promote CD8(+) T cell-mediated anti-tumor immunity
por: Shao, Dong, et al.
Publicado: (2022)

The CXCL10/CXCR3 Pathway Contributes to the Synergy of Thermal Ablation and PD-1 Blockade Therapy against Tumors
por: Xiao, Wenlu, et al.
Publicado: (2023)

Upregulation of METTL3 Expression Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma
por: Xia, Tian-Liang, et al.
Publicado: (2020)

CXCL5 expression in tumor tissues is associated with poor prognosis in patients with pancreatic cancer
por: Wu, Bin, et al.
Publicado: (2020)

The study of METTL3 and METTL14 expressions in childhood ETV6/RUNX1‐positive acute lymphoblastic leukemia
por: Sun, Congcong, et al.
Publicado: (2019)

HIV Replication Is Increased by RNA Methylation METTL3/METTL14/WTAP Complex Activators
por: Selberg, Simona, et al.
Publicado: (2021)

Analysis of METTL3 and METTL14 in hepatocellular carcinoma
por: Liu, Xiangxiang, et al.
Publicado: (2020)

METTL3 is essential for postnatal development of brown adipose tissue and energy expenditure in mice
por: Wang, Yuqin, et al.
Publicado: (2020)

LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis
por: Xie, Jian, et al.
Publicado: (2021)

LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer
por: Song, Zhengwei, et al.
Publicado: (2022)

The Distinct Function and Localization of METTL3/METTL14 and METTL16 Enzymes in Cardiomyocytes
por: Arcidiacono, Orazio Angelo, et al.
Publicado: (2020)

Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma
por: Yang, Min, et al.
Publicado: (2018)

Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma
por: Wang, Yi, et al.
Publicado: (2021)

Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumors
por: Lin, Liang-Yu, et al.
Publicado: (2017)

Elevated expression of SATB1 is involved in pancreatic tumorigenesis and is associated with poor patient survival
por: Guo, Lei, et al.
Publicado: (2017)

High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma
por: Ye, Yibiao, et al.
Publicado: (2015)

METTL3 increases cisplatin chemosensitivity of cervical cancer cells via downregulation of the activity of RAGE
por: Li, Ruyi, et al.
Publicado: (2021)

Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma
por: Dong, Shu, et al.
Publicado: (2019)

A real-life treatment cohort of pancreatic neuroendocrine tumors: High-grade increase in metastases confers poor survival
por: Zhang, Wu-Hu, et al.
Publicado: (2022)

Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
por: Kahlert, C, et al.
Publicado: (2009)

LAG-3 expression on tumor-infiltrating T cells in soft tissue sarcoma correlates with poor survival
por: Que, Yi, et al.
Publicado: (2019)

A METTL3-METTL14 complex mediates mammalian nuclear RNA N(6)-adenosine methylation
por: Liu, Jianzhao, et al.
Publicado: (2013)

Novel insights into the METTL3-METTL14 complex in musculoskeletal diseases
por: Xu, Yeqiu, et al.
Publicado: (2023)

METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma
por: Lu, Liting, et al.
Publicado: (2022)

WTAP–VIRMA counteracts dsDNA binding of the m(6)A writer METTL3–METTL14 complex and maintains N(6)-adenosine methylation activity
por: Yan, Xuhui, et al.
Publicado: (2023)

Mettl3 deficiency leads to the upregulation of Cav1.2 and increases arrhythmia susceptibility in mice: Mettl3 regulates L-type Ca currents of cardiomyocytes
por: Shi, Ling, et al.
Publicado: (2022)

Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
por: Chen, Lujun, et al.
Publicado: (2019)

Opposing regulation of the Nα-trimethylase METTL11A by its family members METTL11B and METTL13
por: Parker, Haley V., et al.
Publicado: (2023)

Increased SPHK1 and HAS2 Expressions Correlate to Poor Prognosis in Pancreatic Cancer
por: Yu, Mengsi, et al.
Publicado: (2021)

Increased METTL3-mediated m(6)A methylation inhibits embryo implantation by repressing HOXA10 expression in recurrent implantation failure
por: Xue, Pingping, et al.
Publicado: (2021)

Mettl14-mediated m6A modification is essential for visual function and retinal photoreceptor survival
por: Yang, Yeming, et al.
Publicado: (2022)

METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression
por: Wei, Wei, et al.
Publicado: (2023)

A cleaved METTL3 potentiates the METTL3–WTAP interaction and breast cancer progression
por: Yan, Chaojun, et al.
Publicado: (2023)

METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications
por: Jian, Dongdong, et al.
Publicado: (2020)

Oxford on Its Mettle
Publicado: (1891)

Cannot write session to /tmp/vufind_sessions/sess_na3doa739hv8p7pijaiohta74n